You have 9 free searches left this month | to do more
Showing 1 - 25 of
>10,000 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
AMG 176 With Azacitidine in Subjects With Myelodysplastic Syndrome /Chronic Myelomonocytic Leukemia
Not yet recruiting
  • Higher Risk Myelodysplastic Syndrome
  • Chronic Myelomonocytic Leukemia
  • (no location specified)
2022-01-13
Jan 13, 2022
B
A Study of Azacitidine in Participants With International Prognostic Scoring System (IPSS) Intermediate-2 and High-risk Myelodysplastic Syndromes (MDS), or Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML)
Not yet recruiting
  • Myelodysplastic Syndromes
  • +2 more
    • (no location specified)
    2022-01-20
    Jan 20, 2022
    G
    Classical Monocyte Kinetics in Chronic Myelomonocytic Leukemia
    Recruiting
    • Myelomonocytic Leukemia
    • Deuterium Glucose
    • Villejuif, Val De Marne, France
      Gustave Roussy
    2021-02-26
    Feb 26, 2021
    N
    TAK-243 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Refractory Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
    Not yet recruiting
    • Myelodysplastic Syndrome
    • +4 more
    • UAE Inhibitor TAK-243
    • (no location specified)
    2022-03-25
    Mar 25, 2022
    M
    Tagraxofusp and Decitabine for the Treatment of Chronic Myelomonocytic Leukemia
    Recruiting
    • Chronic Myelomonocytic Leukemia
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    2022-03-04
    Mar 4, 2022
    K
    Study of Tagraxofusp for Post-Transplant Maintenance for Patients With CD 123+ AML, MF and CMML (HSCT 002)
    Not yet recruiting
    • Myelofibrosis
    • +2 more
    • Charlottesville, Virginia
      Danyelle Coley
    2022-01-31
    Jan 31, 2022
    K
    Tipifarnib in Subjects With Chronic Myelomonocytic Leukemia, Other MDS/MPN, and Acute Myeloid Leukemia - 2020
    Completed
    • Leukemia, Myelomonocytic, Chronic
    • Scottsdale, Arizona
    • +7 more
    2021-05-12
    May 12, 2021
    M
    Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML) - 2021
    Completed
    • Juvenile Myelomonocytic Leukemia
    • Stem Cell Transplant
    • Preparative Regimen
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    2021-08-09
    Aug 9, 2021
    M
    Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate - 2013
    Completed
    Has Results
    • Chronic Myelomonocytic Leukemia
    • +4 more
    • Imatinib Mesylate (Gleevec)
    • Houston, Texas
      UT MD Anderson Cancer Center
    2021-12-07
    Dec 7, 2021
    M
    Seclidemstat and Azacitidine for the Treatment of Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
    Recruiting
    • Chronic Myelomonocytic Leukemia-0
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    2022-01-18
    Jan 18, 2022
    T
    Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation
    Recruiting
    • Leukemia
    • +2 more
    • Enasidenib mesylat dose escalation
    • Palo Alto, California
      Stanford Cancer Institute
    2022-03-07
    Mar 7, 2022
    R
    Study to Evaluate the Safety, Pharmacokinetics and Clinical Activity of RP7214 in Combination With Azacitidine in Patients With Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia
    Not yet recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • (no location specified)
    2022-02-17
    Feb 17, 2022
    M
    Inqovi Maintenance Therapy in Myeloid Neoplasms
    Recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    2021-09-29
    Sep 29, 2021
    M
    Fostamatinib for the Treatment of Lower-risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia Who Have Failed Therapy With Hypomethylating Agents
    Recruiting
    • Refractory Chronic Myelomonocytic Leukemia
    • Refractory Myelodysplastic Syndrome
    • Houston, Texas
      M D Anderson Cancer Center
    2021-08-31
    Aug 31, 2021
    O
    Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant
    Recruiting
    • Acute Myeloid Leukemia
    • +6 more
    • Hyperbaric oxygen
    • Rochester, New York
      Wilmot Cancer Institute, University of Rochester
    2022-01-12
    Jan 12, 2022
    H
    Ruxolitinib for the Treatment of Chronic Myelomonocytic Leukemia (CMML): A Phase 2 Expansion
    Recruiting
    • Chronic Myelomonocytic Leukemia
    • Leukemia
    • Tampa, Florida
    • +4 more
    2022-01-26
    Jan 26, 2022
    D
    A Phase 1 Trial of CD25/Treg-depleted DLI Plus Ipilimumab for Myeloid Disease Relapse After Matched-HCT
    Recruiting
    • Acute Myeloid Leukemia
    • +4 more
    • Boston, Massachusetts
    • +1 more
    2022-01-12
    Jan 12, 2022
    K
    A Study of Dual-SIgnaling Protein 107 (DSP107) for Patients With Hematological Malignancies
    Recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • DSP107
    • +2 more
    • Houston, Texas
      The University of Texas MD Anderson Cancer Center, Department of
    2022-01-27
    Jan 27, 2022
    M
    Venetoclax in Combination With ASTX727 for the Treatment of Treatment-Naive High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
    Recruiting
    • Chronic Myelomonocytic Leukemia
    • Myelodysplastic Syndrome
    • Houston, Texas
      M D Anderson Cancer Center
    2021-10-27
    Oct 27, 2021
    B
    A Study of BLEX 404 Oral Liquid in Patients With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-Risk Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML)
    Not yet recruiting
    • Myelodysplastic Syndrome (MDS)
    • BLEX 404 Oral Liquid
    • (no location specified)
    2021-09-07
    Sep 7, 2021
    H
    Phase II Hedgehog Inhibitor for Myelodysplastic Syndrome (MDS) - 2021
    Completed
    Has Results
    • Myelodysplastic Syndrome (MDS)
    • Chronic Myelomonocytic Leukemia (CMML)
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    2021-06-10
    Jun 10, 2021
    U
    Myeloproliferative Neoplasms (MPNs) Patient Registry
    Recruiting
    • Primary Myelofibrosis
    • +9 more
    • Observational
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    2021-04-01
    Apr 1, 2021
    M
    Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm
    Recruiting
    • Recurrent Acute Myeloid Leukemia
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    2021-06-30
    Jun 30, 2021
    C
    Allogeneic Stem Cell Transplantation Followed By Targeted Immune Therapy In Average Risk Leukemia - 2020
    Completed
    • Acute Myelogenous Leukemia
    • +2 more
    • New York, New York
      Columbia University Medical Center
    2021-08-04
    Aug 4, 2021
    F
    Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
    Not yet recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    2022-03-07
    Mar 7, 2022